Conclusion: Our study underscores the potential use of TARGIT-IORT as a viable treatment option for breast cancer patients with intellectual and psychiatric disabilities. Unlike traditional EBRT, TARGIT-IORT offers a single radiation dose, addressing challenges associated with co...
Chemotherapy is a treatment option for most forms of breast cancer. It can be used for treating early and locally advanced breast cancer as well as metastatic disease. Chemotherapy might also be called antineoplastic or cytotoxic therapy.Neoadjuvant chemotherapy is chemotherapy given before surgery to ...
Patient and Methods: 25 patients with stage 1 or 2 breast cancer, with a tumor size not more than 3 cmin its greatest dimension, were operated upon by quadrantectomy, and bilateral reduction mammaplasty. Oncologic data on tumor size, location, and axillary lymph node, were assessed, and ...
Surgeries on breast cancer have provided relief for many. This is one of the go-to breast cancer treatments the doctors generally use. There are two types of surgeries that doctors recommend. An option is a mastectomy where the whole breast gets removed — another other is a lumpectomy or b...
“The future of breast cancer surgery is one where we can achieve minimal change to a woman’s body image and quality of life, and give our patients the confidence and courage to face the rest of her treatments.” Oncoplastic surgery: A new option ...
Preoperative SBRT is a promising treatment option for breast cancer patients. The precise localization of the irradiated area (targeting the tumor rather than the tumor bed) is a notable feature. Early treatment toxicity is reported to be relatively low. However, the existing data are derived from...
For an individual lesion, DCIS breast-conserving therapy is an option, but if there are multiple DCIS lesions, doing multiple lumpectomies can be difficult. That’s where one could consider mastectomy,” said Bardia, an attending physician at Massachusetts General Hospital Cancer Center and an ass...
21 In 2021, the National Comprehensive Cancer Network (NCCN) guidelines highlighted the combination of atezolizumab and bevacizumab as the preferred first-line treatment option for patients with hepatocellular carcinoma (HCC).22 This recommendation underscores the importance of immunotherapy and anti-...
Treatment for breast cancer is determined by the type of breast cancer, stage and grade, size of tumor and sensitivity of cancer cells to hormones. Most common types of treatment involve surgery and potentially additional post-surgery treatment including chemotherapy, hormone therapy or radiation. ...
"We believe the once-weekly regimen such as this will become a standard option in the next decade," he said. The interim results of the trial were presented Thursday at the Breast Cancer Symposium 2014 in San Francisco.